MBO of Ceva Santé Animale backed by Sofiproteol, Temasek, CDH Investments, Euromezzanine and Sagard
|Client||Sofiprotéol (leading player in the French vegetable oil and protein industry)|
|Deal Type||Buy-side Advisory (MBO)|
|Deal||Sofiprotéol, together with other investors (Temasek, CDH Investments and the historical partners of the group: Euromezzanine and Sagard), invested alongside the management in Ceva Santé Animale (global veterinary health company). This is 4th LBO of the group.|
What we did:
- Actively supported Sofiprotéol alongside all the acquisition process: negotiating with Ceva Santé Animale, providing valuation guidance, execution support, mapping out negotiation arguments and negotiating legal documentation.
- Played a key role in explaining and negotiating the deal structure and related shareholders’ agreement of this fairly complex LBO.